Serdar Özbaş

11PUBLICATIONS
63CO-AUTHORS
Immunogenetics (incl. genetic immunology)Cancer therapy (excl. chemotherapy and radiation therapy)Oncology and carcinogenesis not elsewhere classifiedEnglish languagePredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Mar 24, 2026
Pittsburgh Classification and Treatment Algorithm for Idiopathic Granulomatous Mastitis: A Multicenter Cohort Study.

Atilla Soran, Merve Tokoçin, Hüseyin Özgür Aytaç

|Oct 28, 2025
Locoregional Treatment in De Novo Bone-Only Metastatic Breast Cancer: Prospective, Multi-Institutional Real-World Data, BOMETIN, Protocol MF14-1a.

Atilla Soran, Berk Göktepe, Berkay Demirors

|Jun 26, 2025
A Pragmatic Grouping Model for Bone-Only De Novo Metastatic Breast Cancer (MetS Protocol MF22-03).

Berk Goktepe, Berkay Demirors, Kazim Senol

|Oct 30, 2024
Combined analysis of the MF18-02/MF18-03 NEOSENTITURK studies: ypN-positive disease does not necessitate axillary lymph node dissection in patients with breast cancer with a good response to neoadjuvant chemotherapy as long as radiotherapy is provided.

Mahmut Muslumanoglu, Neslihan Cabioglu, Abdullah Igci

|Apr 07, 2023
The Role of Primary Surgery in De Novo Metastatic Breast Carcinoma.

Berkay Demirors, Berk Goktepe, Hannah Medeck

|Jul 20, 2022
The Senologic International Society Survey on Ductal Carcinoma In Situ: Present and Future.

Carole Mathelin, Massimo Lodi, Khalid Alghamdi

Pageof 2

Frequent Collaborators

4 joint publications

Atilla Soran

3 joint publications

Berk Goktepe

3 joint publications

Berkay Demirors

3 joint publications

Vahit Özmen